In vitro diagno substances, reagents
Ended Awarded Last action
- Contract number
- HHSN261201000025I
- Awardee
-
Asterand US Acquistion Corporation UEI D8DBNBJL5MY7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $98,100 obligated
Award facts
- Opportunity
-
- RFQNCI100019 Solicitation number
- RECOVERY- Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $98,100 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 55% used
- $180,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to Asterand US Acquisition Corporation (Asterand Biosciences) in the amount of $180,000. The contract is for the Recovery Act Tissue Samples and Data from Various Cancer Types for the Cancer Genome Atlas (TCGA) Program, which is under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract has a total small business set-aside designation and a period of performance ending on September 30, 2014. The contract is a firm-fixed price type.
A $98,100 delivery order was subsequently issued under this IDV to Asterand US Acquisition Corporation (Asterand Biosciences) for the Recovery Act Tissue Samples and Data from Various Cancer Types for the TCGA Program. This delivery order has a period of performance ending on August 22, 2013 and is also a firm-fixed price contract.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Recovery act tissue samples and data from various cancer types for the cancer genome atlas (TCGA) program. | National Cancer Institute (NIH) | $98,100 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Novation Agreement | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000025I?
HHSN261201000025I was awarded to Asterand US Acquistion Corporation by National Cancer Institute (National Institutes of Health) on March 19, 2010.
How much is contract HHSN261201000025I worth?
Orders under HHSN261201000025I have obligated $98,100. HHSN261201000025I's own ceiling is $180,000.
How many orders have been placed under contract HHSN261201000025I?
1 order has been placed under HHSN261201000025I, the latest on March 24, 2010.
Who can order from contract HHSN261201000025I?
HHSN261201000025I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000025I part of a contract vehicle?
Yes. HHSN261201000025I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000025I competed?
The extent of competition for HHSN261201000025I was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV